The material of the SCOPE Final Conference "SCREENING for CKD among OLDER people across EUROPE" is now available.



Morning session

SCOPE Project - Fabrizia Lattanzio, MD INRCA

Innovative biomarkers for CKD, Johan Ärnlöv, MD, Axel C. Carlsson, MD, Karolinska Institute

Findings from the Screening for Chronic Kidney Disease among Older People across Europe (SCOPE) project - Fabrizia Lattanzio, MD, Andrea Corsonello, MD IRCCS INRCA

ProtocoL for GFR measurement USing ioexol: the SCOPE+ substudySabine Zitta, MD, Medical University of Graz

SCOPE Massive open online courses (MOOCs) for longdistance education in geriatric medicine across EuropeRegina Roller-Wirnsberger MD, Medical University of Graz


Afternoon session

Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance

Fabrizia Lattanzio, MD, Andrea Corsonello, MD IRCCS INRCA

Association between kidney function, nutritional status and anthropometric measures in older people

Tomasz Kostka, MD, Agnieszka Guligowska, MD, Medical University of Lodz

Prevalence of sarcopenia in community-dwelling older adults using the updated EWGSOP2 definition according to kidney function and albuminuria

Francesc Formiga, MD, Rafael Moreno-González, MD, Bellvitge University Hospital – IDIBELL

Kidney function and other factors and their association with falls

Cornel Sieber, MD, Ellen Freiberger, MD, Robert Kob, Friedrich-Alexander Universität Erlangen-Nürnberg

Is kidney function associated with cognition and mood in late life? 

Francesco Mattace-Raso, MD, Lisanne Tap, MD, ERASMUS Medical Centre

Impaired kidney function is associated with lower quality of life among community-dwelling older adultsItshak Melzer, MD, Rada Artzi-Medvedik, MD, Ben-Gurion University of the Negev

The link of the event are here available:

Morning session

Afternoon session

For further information please contact This email address is being protected from spambots. You need JavaScript enabled to view it. 

“SCREENING for CKD among OLDER people across EUROPE”

Final Conference (Virtual Event)

SCOPE project coordinator and consortium partners are pleased to invite you to the “SCREENING for CKD among OLDER people across EUROPE” Final Conference (Virtual Event) that will take place on Wednesday November 25th, 2020. 

The event, organized within the framework of the H2020 Project “Screening for CKD among older people across Europe (SCOPE)”, funded by the European Commission, aims at providing evidence for existing screening and prevention programmes (Work Programme Health, demographic change and wellbeing) in the field of Chronic Kidney Disease (CKD).

The SCOPE project investigated whether and to which extent currently available screening methods may identify older people at risk of worsening kidney function, thanks to the implementation of an observational prospective study with a 2-year follow up, recruiting 2435 older people aged 75+ in seven Italy, Austria, Israel, the Netherlands, Sweden, Spain, Poland, and Germany and Israel.

The SCOPE Final Conference, which is organized in close cooperation with the project partners: Ben-Gurion University of the Negev, Erasmus University Medical Centre, Rotterdam, Medical University of Graz, Austria, Servicio Madrileño de Salud, Fundación para la Investigación Biomédica del Hospital Clínico San Carlos, and Institut Català de la Salut – Hospital Universitari de Bellvitge, Spain, University of Lodz, Poland, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany and Uppsala University, Sweden, will give new insights into screening strategies in a population at high risk of developing kidney function decline like older patients, presenting final results from the study. In particular, it will shed light on the first findings from cross-sectional analysis published in the BMC Geriatrics Journal and on the MOOC developed during the SCOPE project.

The conference will be held in English and to participate you will have to fill in the registration form where you will have to specify your name, the organization you represent, your function and email address. 

We look forward to welcoming you in the virtual room of this event.

SCOPE Final Agenda


SCREENING for CKD among OLDER people across EUROPE

Final Conference - Virtual Event

November 25th 2020


Preliminary results from the baseline database of the SCOPE Project was made available in the BMC Geriatric Special Issue

CKD and Quality of Life

Quality of life (QoL) refers to the physical, psychological, social, and medical aspects of life that are influenced by health status and functions. The SCOPE team investigated the QoL among older in early stage of CKD, to identify the factors that influence this relationship. The study results showed that CKD and its severity may be significantly associated with impaired QoL among community-dwelling older people.

Is kidney function associated with cognition and mood in late life?

The prevalence of CKD and cognitive impairment is growing as a result of the aging population. CKD, cognitive impairment, and mood disorder share common risk factors. Whether a decreased kidney function is associated with cognitive and mood disorders in the oldest old is not completely clear. Therefore, the SCOPE team has investigated for the first time the possible association between kidney function, cognition and mood. The study results showed that the prevalence of cognitive impairment and depressive symptoms does not increase among older people in more advanced stages of CKD.

Is CKD a predictor of falls?

Falls are a serious negative health outcome in older persons. In facts, the fall rate rises with increasing age. However, the impact of CKD on falls in older community-dwelling persons is not well investigated yet, especially in relation to the urinary tract symptoms (LUTS). The SCOPE team studied the impact of CKD and LUTS on falls as well as on injurious falls. The study results showed that lower urinary tract symptoms are a predictor of falls and injurious falls, while the association between CKD and falls needs to be prospectively investigated.

CKD and Sarcopenia

Loss of muscle mass and function (sarcopenia) may be more pronounced in older adults with CKD, wherein the protein albumin is abnormally present in the urine (albuminuria). The SCOPE team investigated the prevalence of sarcopenia among community-dwelling older adults according to kidney function and albuminuria levels. The study results showed that sarcopenia is common among older adults, especially those in more advanced CKD stages, even if the estimated prevalence slightly differs depending on the equation used to assess estimated Glomerular Filtration Rate (eGFR); likewise, sarcopenia seems to be widespread among older people with higher albuminuria levels.

Association between kidney function and nutritional status

Different mechanisms connect the nutritional status with the occurrence and the course of CKD. Existing literature shows that especially during end-stage renal disease, there are complications that lead to malnutrition (undernutrition). However, the SCOPE team has further investigated this relationship between kidney function and nutritional status. The study results showed that population of community-dwelling 75+ with CKD show general features of overweight and obesity with a small prevalence of malnutrition.

CKD in multimorbidity patterns

CKD is known to be associated with several co-occurring conditions. The SCOPE team has explored multimorbidity patterns, as well as the impact of physical performance and CKD severity among an older community-dwelling people. The study results showed that CKD contributes significantly to multimorbidity patterns in a population of older outpatients and it was rarely observed without any co-occurring diseases. Moreover, CKD may cluster with hypertension and sensory impairments, but its contribution to multimorbidity pattern may be affected by CKD severity.

These scientific results prompt to further improve the screening methods for CKD in the older population and the models of assistance and care through longitudinal studies. The early diagnosis of CKD represents a priority issue to be addressed to prevent / slow its progression among older patients and, at the same time, to reduce the need for long-term care and the related cost for the healthcare system.

The SCOPE cohort study completed all the expected Follow Ups (FU6, FU12, FU18, FU24) in 7 EU centres plus Israel.

All the partners finalized the dataentry and after the completion of the cleaning/freeze of the database the SCOPE consortium will focus on the related analysis.